Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

VitaNova Life Sciences (YJGJ) Cost of Revenue (2017 - 2025)

VitaNova Life Sciences (YJGJ) has disclosed Cost of Revenue for 4 consecutive years, with $2900.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Cost of Revenue fell 97.87% year-over-year to $2900.0, compared with a TTM value of $945981.0 through Oct 2025, up 469.88%, and an annual FY2025 reading of $1.1 million, up 4689.47% over the prior year.
  • Cost of Revenue was $2900.0 for Q4 2025 at VitaNova Life Sciences, down from $824075.0 in the prior quarter.
  • Across five years, Cost of Revenue topped out at $824075.0 in Q2 2025 and bottomed at $2900.0 in Q4 2025.